May 22 (Reuters) - Mgc Pharmaceuticals Ltd MXC.AX
* Has received very positive results from final phase clinical tests on co's new proprietary dermatological products
* Mgc pharmaceuticals ltd says new dermatological product range to launch in q3 2017 Source text for Eikon: ID:nASXSx706 Further company coverage: MXC.AX